Netazepide

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameNetazepide
Drug Alias NameNetazepida奈他西匹奈塔西派NetazepidumYF-476 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholecystokinin B receptor antagonists
TargetsCholecystokinin B receptor
Therapy Area/IndicationsGastritis, AtrophicEsophagitis, PepticBarrett Esophagus +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNorwayUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesFerring Bv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFerring BvColumbia UniversityTrio Medicines Ltd
Active IndicationsN/A
Inactive IndicationsGastritis, AtrophicEsophagitis, PepticBarrett Esophagus +[5] 

Other Information

ATC CodeN/A
Related LinksN/A